 SAN DIEGO, CA ACCESSWIRE May 12, 2021 Obalon Therapeutics, Inc. NASDAQ:OBLN is urging its stockholders to IMMEDIATELY vote FOR the proposals put forth in its proxy statement to be voted on at the May 13, 2021 special meeting of stockholders, all of which relate to the proposed merger with ReShape Lifesciences Inc., a global weight-loss solutions company offering an integrated portfolio of proven products and services that manage and treat obesity and associated metabolic disease. We are urging all of our stockholders to take a few minutes to vote by phone or email on this important transaction, said Obalon CEO Andrew Rasdal. 